title: Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.
abstract: OBJECTIVE
  To investigate the association of hippocampal sclerosis (HS) with TAR-DNA binding protein of 43kDa (TDP-43) and other common age-related pathologies, dementia, probable Alzheimer disease (AD), mild cognitive impairment (MCI), and cognitive domains in community-dwelling older subjects.
  
  
  METHODS
  Diagnoses of dementia, probable AD, and MCI in 636 autopsied subjects from the Religious Order Study and the Rush Memory and Aging Project were based on clinical evaluation and cognitive performance tests. HS was defined as severe neuronal loss and gliosis in the hippocampal CA1 and/or subiculum. The severity and distribution of TDP-43 were assessed, and other age-related pathologies were also documented.
  
  
  RESULTS
  HS was more common in those aged >90 years (18.0%) compared to younger subjects (9.2%). HS cases commonly coexisted with TDP-43 pathology (86%), which was more severe (p < 0.001) in HS cases. Although HS also commonly coexisted with AD and Lewy body pathology; only TDP-43 pathology increased the odds of HS (odds ratio [OR] = 2.63, 95% confidence interval [CI] = 2.07-3.34). In logistic regression models accounting for age, TDP-43, and other common age-related pathologies, HS cases had higher odds of dementia (OR = 3.71, 95% CI = 1.93-7.16), MCI, and probable AD (OR = 3.75, 95% CI = 2.01-7.02). In linear regression models, including an interaction term for HS and TDP-43 pathology, HS with coexisting TDP-43 was associated with lower function in multiple cognitive domains, whereas HS without TDP-43 did not have statistically significant associations. TDP-43 without HS was separately related to lower episodic memory.
  
  
  CONCLUSIONS
  The combined roles of HS and TDP-43 pathology are significant factors underlying global cognitive impairment and probable AD in older subjects.
authors.affiliation: Rush Alzheimer's Disease Center.|Departments of Pathology (Neuropathology).
authors.forename: Sukriti
authors.initials: S
authors.lastname: Nag
authors.affiliation: Rush Alzheimer's Disease Center.|Departments of Neurological Sciences.
authors.forename: Lei
authors.initials: L
authors.lastname: Yu
authors.affiliation: Rush Alzheimer's Disease Center.|Departments of Neurological Sciences.
authors.forename: Ana W
authors.initials: AW
authors.lastname: Capuano
authors.affiliation: Rush Alzheimer's Disease Center.|Departments of Neurological Sciences.|Behavioral Sciences, Rush University Medical Center, Chicago, IL.
authors.forename: Robert S
authors.initials: RS
authors.lastname: Wilson
authors.affiliation: Rush Alzheimer's Disease Center.|Departments of Neurological Sciences.
authors.forename: Sue E
authors.initials: SE
authors.lastname: Leurgans
authors.affiliation: Rush Alzheimer's Disease Center.|Departments of Neurological Sciences.
authors.forename: David A
authors.initials: DA
authors.lastname: Bennett
authors.affiliation: Rush Alzheimer's Disease Center.|Departments of Pathology (Neuropathology).|Departments of Neurological Sciences.
authors.forename: Julie A
authors.initials: JA
authors.lastname: Schneider
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000378:metabolism / Q000473:pathology*; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology*; D060825:Cognitive Dysfunction / Q000378:metabolism / Q000473:pathology*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005260:Female; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D008297:Male; D012598:Sclerosis / Q000473:pathology
chemical_list: D004268:DNA-Binding Proteins